BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, Riwes MM, Kennel M, Antin JH, Cutler CS, Ho VT, Alyea EP 3rd, Parkin BL, Yanik GA, Choi SW, Lewis EC, Dinarello CA, Koreth J, Reddy P. α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood 2018;131:1372-9. [PMID: 29437593 DOI: 10.1182/blood-2017-11-815746] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 Agné A, Richter K, Padberg W, Janciauskiene S, Grau V. Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β. Pulm Pharmacol Ther 2021;68:102020. [PMID: 33774155 DOI: 10.1016/j.pupt.2021.102020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Schroeder MA, Khoury HJ, Jagasia M, Ali H, Schiller GJ, Staser K, Choi J, Gehrs L, Arbushites MC, Yan Y, Langmuir P, Srinivas N, Pratta M, Perales MA, Chen YB, Meyers G, DiPersio JF. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease. Blood Adv 2020;4:1656-69. [PMID: 32324888 DOI: 10.1182/bloodadvances.2019001043] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 25.0] [Reference Citation Analysis]
3 Song S. Alpha-1 Antitrypsin Therapy for Autoimmune Disorders. Chronic Obstr Pulm Dis 2018;5:289-301. [PMID: 30723786 DOI: 10.15326/jcopdf.5.4.2018.0131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Toubai T, Magenau J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease. Blood 2020;136:429-40. [PMID: 32526035 DOI: 10.1182/blood.2019000953] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
5 Kim S, Reddy P. Targeting Signal 3 Extracellularly and Intracellularly in Graft-Versus-Host Disease. Front Immunol 2020;11:722. [PMID: 32411139 DOI: 10.3389/fimmu.2020.00722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shapiro RM, Antin JH. Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape. Expert Rev Hematol 2020;13:519-32. [PMID: 32249631 DOI: 10.1080/17474086.2020.1752175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Turki AT, Bayraktar E, Basu O, Benkö T, Yi JH, Kehrmann J, Tzalavras A, Liebregts T, Beelen DW, Steckel NK. Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract. Ann Hematol 2019;98:2407-19. [PMID: 31338570 DOI: 10.1007/s00277-019-03754-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Brami I, Ini D, Sassonker N, Zaknoun M, Zuckerman T, Lewis EC. Immunosuppressive Drugs Alter α1-Antitrypsin Production in Hepatocytes: Implications for Epithelial Gap Repair. Biol Blood Marrow Transplant 2020;26:625-33. [PMID: 31899361 DOI: 10.1016/j.bbmt.2019.12.764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vaidya T, Menzer C, Ponce DM, Markova A. Inpatient Management of Mucocutaneous GVHD. Curr Dermatol Rep 2019;8:258-78. [PMID: 33312761 DOI: 10.1007/s13671-019-00280-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 DiMaggio E. Acute Graft-versus-Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment. Pharmacotherapy 2020;40:788-807. [PMID: 32530080 DOI: 10.1002/phar.2436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 McKimpson WM, Chen Y, Irving JA, Zheng M, Weinberger J, Tan WLW, Tiang Z, Jagger AM, Chua SC Jr, Pessin JE, Foo RS, Lomas DA, Kitsis RN. Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes. Dev Cell 2021;56:747-760.e6. [PMID: 33667344 DOI: 10.1016/j.devcel.2021.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Giannoni L, Morin F, Robin M, Peyneau M, Schlageter MH, Desmier D, Pagliuca S, Sutra Del Galy A, Sicre de Fontbrune F, Xhaard A, Dhedin N, Moins-Teisserenc H, Peffault de Latour R, Socié G, Michonneau D. Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant 2020;26:1620-6. [PMID: 32454215 DOI: 10.1016/j.bbmt.2020.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Schuster R, Motola-kalay N, Baranovski BM, Bar L, Tov N, Stein M, Lewis EC, Ayalon M, Sagiv Y. Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action. Cellular Immunology 2020;356:104177. [DOI: 10.1016/j.cellimm.2020.104177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Crocetti L, Quinn M, Schepetkin I, Giovannoni M. A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications. Expert Opinion on Therapeutic Patents 2019;29:555-78. [DOI: 10.1080/13543776.2019.1630379] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
15 Kasikis S, Etra A, Levine JE. Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease. BioDrugs 2021;35:19-33. [PMID: 33201499 DOI: 10.1007/s40259-020-00454-7] [Reference Citation Analysis]
16 Hill GR, Betts BC, Tkachev V, Kean LS, Blazar BR. Current Concepts and Advances in Graft-Versus-Host Disease Immunology. Annu Rev Immunol 2021;39:19-49. [PMID: 33428454 DOI: 10.1146/annurev-immunol-102119-073227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Malard F, Huang XJ, Sim JPY. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. Leukemia 2020;34:1229-40. [PMID: 32242050 DOI: 10.1038/s41375-020-0804-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
18 Holler E, Greinix H, Zeiser R. Acute Graft-Versus-Host Disease. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook. Cham: Springer International Publishing; 2019. pp. 323-30. [DOI: 10.1007/978-3-030-02278-5_43] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
19 Abedin S, Hamadani M. Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease. J Exp Pharmacol 2020;12:549-57. [PMID: 33273867 DOI: 10.2147/JEP.S259290] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mcnulty MJ, Silberstein DZ, Kuhn BT, Padgett HS, Nandi S, Mcdonald KA, Cross CE. Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives. Free Radical Biology and Medicine 2021;163:10-30. [DOI: 10.1016/j.freeradbiomed.2020.11.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sumransub N, El Jurdi N, Chiraphapphaiboon W, Maakaron JE. Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies. Blood Rev 2021;:100883. [PMID: 34429234 DOI: 10.1016/j.blre.2021.100883] [Reference Citation Analysis]
22 Zamora M. Surgery for patients with Alpha 1 Antitrypsin Deficiency: A review. The American Journal of Surgery 2019;218:639-47. [DOI: 10.1016/j.amjsurg.2018.10.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Jagasia M, Perales MA, Schroeder MA, Ali H, Shah NN, Chen YB, Fazal S, Dawkins FW, Arbushites MC, Tian C, Connelly-Smith L, Howell MD, Khoury HJ. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial. Blood 2020;135:1739-49. [PMID: 32160294 DOI: 10.1182/blood.2020004823] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 64.0] [Reference Citation Analysis]
24 Jenkins A, Lengyel I, Rutter GA, Lowe N, Shai I, Tirosh A, Petro T, Khamaisi M, Andrews S, Zmora N, Gross A, Maret W, Lewis EC, Moran A. Obesity, diabetes and zinc: A workshop promoting knowledge and collaboration between the UK and Israel, november 28-30, 2016 - Israel. J Trace Elem Med Biol 2018;49:79-85. [PMID: 29895375 DOI: 10.1016/j.jtemb.2018.04.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Gergoudis SC, DeFilipp Z, Özbek U, Sandhu KS, Etra AM, Choe HK, Kitko CL, Ayuk F, Aziz M, Baez J, Ben-David K, Bunworasate U, Gandhi I, Hexner EO, Hogan WJ, Holler E, Kasikis S, Kowalyk SM, Lin JY, Merli P, Morales G, Nakamura R, Reshef R, Rösler W, Srinagesh H, Young R, Chen YB, Ferrara JLM, Levine JE. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin. Blood Adv 2020;4:6098-105. [PMID: 33351103 DOI: 10.1182/bloodadvances.2020003336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Levine JE, Antin JH, Allen CE, Burroughs LM, Cooke KR, Devine S, Heslop H, Nakamura R, Talano JA, Yanik G, DiFronzo N. Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant 2020;26:e94-e100. [PMID: 32035274 DOI: 10.1016/j.bbmt.2020.01.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lia G, Giaccone L, Leone S, Bruno B. Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role? Front Immunol 2021;12:641427. [PMID: 34093530 DOI: 10.3389/fimmu.2021.641427] [Reference Citation Analysis]
28 Hildebrandt GC, Chao N. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation. Br J Haematol 2020;190:508-19. [PMID: 32319084 DOI: 10.1111/bjh.16621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
29 Gooptu M, Antin JH. GVHD Prophylaxis 2020. Front Immunol 2021;12:605726. [PMID: 33897681 DOI: 10.3389/fimmu.2021.605726] [Reference Citation Analysis]
30 Peltier D, Radosevich M, Ravikumar V, Pitchiaya S, Decoville T, Wood SC, Hou G, Zajac C, Oravecz-Wilson K, Sokol D, Henig I, Wu J, Kim S, Taylor A, Fujiwara H, Sun Y, Rao A, Chinnaiyan AM, Goldstein DR, Reddy P. RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity. Sci Transl Med 2021;13:eaaz0316. [PMID: 33731431 DOI: 10.1126/scitranslmed.aaz0316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Baranovski BM, Schuster R, Nisim O, Brami I, Lior Y, Lewis EC. Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients. Chronic Obstr Pulm Dis 2018;5:267-76. [PMID: 30723784 DOI: 10.15326/jcopdf.5.4.2017.0161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
32 Batgi H, Dal MS, Erkurt MA, Kuku I, Kurtoglu E, Hindilerden IY, Kaya E, Berber I, Ulas T, Altuntas F. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience. Transfus Apher Sci 2021;60:103242. [PMID: 34420882 DOI: 10.1016/j.transci.2021.103242] [Reference Citation Analysis]
33 Chen YH, Cheadle CE, Rice LV, Pfeffer PE, Dimeloe S, Gupta A, Bush A, Gooptu B, Hawrylowicz CM. The Induction of Alpha-1 Antitrypsin by Vitamin D in Human T Cells Is TGF-β Dependent: A Proposed Anti-inflammatory Role in Airway Disease. Front Nutr 2021;8:667203. [PMID: 34458299 DOI: 10.3389/fnut.2021.667203] [Reference Citation Analysis]
34 Elshikha AS, Abboud G, van der Meijden-Erkelens L, Lu Y, Chen MJ, Yuan Y, Ponjee G, Zeumer L, Satoh M, Morel L, Song S. Alpha-1-Antitrypsin Ameliorates Pristane Induced Diffuse Alveolar Hemorrhage in Mice. J Clin Med 2019;8:E1341. [PMID: 31470606 DOI: 10.3390/jcm8091341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Riley L, Lascano J. Clinical outcomes and survival following lung transplantation in patients with Alpha-1 antitrypsin deficiency. Respir Med 2020;172:106145. [PMID: 32911139 DOI: 10.1016/j.rmed.2020.106145] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Thangavelu G, Blazar BR. Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease. Front Immunol 2019;10:309. [PMID: 30906290 DOI: 10.3389/fimmu.2019.00309] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
37 Grander C, Schaefer B, Schwärzler J, Grabherr F, de Graaf DM, Enrich B, Oberhuber G, Mayr L, Sangineto M, Jaschke N, Adolph TE, Effenberger M, Moschen AR, Dinarello CA, Zoller H, Tilg H. Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humans. Gut 2021;70:585-94. [PMID: 32699098 DOI: 10.1136/gutjnl-2020-321375] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Geiger S, Ozay EI, Geumann U, Hereth MK, Magnusson T, Shanthalingam S, Hirsch D, Kälin S, Günther C, Osborne BA, Tew GN, Hermann FG, Minter LM. Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD. Mol Ther 2019;27:1436-51. [PMID: 31138510 DOI: 10.1016/j.ymthe.2019.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Vandenhove B, Canti L, Schoemans H, Beguin Y, Baron F, Graux C, Kerre T, Servais S. How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2020;11:583564. [PMID: 33193397 DOI: 10.3389/fimmu.2020.583564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Dimeloe S, Rice LV, Chen H, Cheadle C, Raynes J, Pfeffer P, Lavender P, Richards DF, Nyon MP, McDonnell JM, Kemper C, Gooptu B, Hawrylowicz CM. Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10. J Steroid Biochem Mol Biol 2019;189:1-9. [PMID: 30690074 DOI: 10.1016/j.jsbmb.2019.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
41 Teshima T, Hill GR. The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models. Front Immunol 2021;12:715424. [PMID: 34489966 DOI: 10.3389/fimmu.2021.715424] [Reference Citation Analysis]
42 Jakimiuk K, Gesek J, Atanasov AG, Tomczyk M. Flavonoids as inhibitors of human neutrophil elastase. J Enzyme Inhib Med Chem 2021;36:1016-28. [PMID: 33980119 DOI: 10.1080/14756366.2021.1927006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]